Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells

Not available.

[1]  S. McColl,et al.  Chemokine-Driven Migration of Pro-Inflammatory CD4+ T Cells in CNS Autoimmune Disease , 2022, Frontiers in Immunology.

[2]  H. Einsele,et al.  Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies , 2022, Blood Cancer Journal.

[3]  A. Laganà,et al.  Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy , 2021, Nature Medicine.

[4]  S. Jagannath,et al.  Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study , 2021, The Lancet.

[5]  H. Goldschmidt,et al.  Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma. , 2021, The New England journal of medicine.

[6]  C. Venugopal,et al.  Strategies to Enhance the Efficacy of T-Cell Therapy for Central Nervous System Tumors , 2020, Frontiers in Immunology.

[7]  Jianfeng Zhou,et al.  CAR T-Cell Therapy Is Effective but Not Long-Lasting in B-Cell Lymphoma of the Brain , 2020, Frontiers in Oncology.

[8]  M. Awais,et al.  IP-10 Promotes Blood–Brain Barrier Damage by Inducing Tumor Necrosis Factor Alpha Production in Japanese Encephalitis , 2018, Front. Immunol..

[9]  Hans Bitter,et al.  Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia , 2018, Nature Medicine.

[10]  David W. Holman,et al.  Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers , 2014, Front. Cell. Neurosci..

[11]  M. Raffeld,et al.  B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma , 2013, Clinical Cancer Research.

[12]  E. Bettelli,et al.  Cutting Edge: Loss of α4 Integrin Expression Differentially Affects the Homing of Th1 and Th17 Cells , 2011, The Journal of Immunology.

[13]  S. McColl,et al.  Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response1 , 2009, The Journal of Immunology.

[14]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[15]  D. Mahad,et al.  Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[16]  Simon A. Jones,et al.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.